Clinical Trial Update: Micafungin Versus Amphotercine B in Treatment of Invasive Fungal Infection [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing micafungin to amphotericin B in neonatal invasive fungal infections has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Fungal Infections
• Neonatal Infections

Drugs mentioned

• Fungizone (amphotericin B)
• Mycamine (Micafungin)

Snippet

Sponsor: Ain Shams University | Conditions: Neonatal Infection, Invasive Fungal Infections | Phase 4 | Status: COMPLETED